DOUGLAS LIENESCH
Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology NEWARK, DE NPI 1124129747
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology DE Amgen Inc. All categories
General Payments — all program years on this page
$439.90
- Category: General Payments
- Program years: PY2018–2024
- Record count: 14
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $247.55 across 10 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $192.56 | 9 |
| Education | $54.99 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $142.77 | 7 |
| Janssen Biotech, Inc. | $54.99 | 1 |
| ABBVIE INC. | $32.75 | 1 |
| Aurinia Pharma U.S., Inc. | $17.04 | 1 |
By program year
Records — PY2024 (10)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078394285 | Janssen Biotech, Inc. | $54.99 | 03/19/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1104881479 | ABBVIE INC. | $32.75 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111634832 | Amgen Inc. | $15.58 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111634834 | Amgen Inc. | $6.08 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111634836 | Amgen Inc. | $26.28 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111634838 | Amgen Inc. | $25.07 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111634840 | Amgen Inc. | $24.64 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111634842 | Amgen Inc. | $21.81 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111634844 | Amgen Inc. | $23.31 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150686283 | Aurinia Pharma U.S., Inc. | $17.04 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.